FHIR © HL7.org  |  FHIRsmith 0.18.1  |  Server Home  |  XIG Home  |  XIG Stats  | 

FHIR IG analytics

Packagede.medizininformatikinitiative.kerndatensatz.onkologie
Resource TypeProcedure
IdProcedure-mii-exa-onko-lv5fu2-phase2.json
FHIR VersionR4

Resources that use this resource

No resources found


Resources that this resource uses

No resources found


Narrative

Note: links and images are rebased to the (stated) source


English


Generated Narrative: Procedure mii-exa-onko-lv5fu2-phase2

MII EX Onko Systemische Therapie Intention: Kurativ

MII EX Onko Systemische Therapie Stellung zur OP: Adjuvant

basedOn: CarePlan: identifier = Tumorkonferenz_FOLFOX_Modification_001; status = active; intent = plan; category = prätherapeutische Tumorkonferenz (Festlegung der Therapiestrategie); created = 2024-03-05

partOf: Procedure Nicht komplexe Chemotherapie

status: Completed

category: Administration of medication

code: Nicht komplexe Chemotherapie

subject: Martin Beispiel Male, DoB: 1958-11-03

encounter: Encounter: status = finished; class = ambulatory (ActCode#AMB)

performed: 2024-06-17 --> 2024-09-10

reasonReference: Condition Bösartige Neubildung: Colon ascendens

outcome: Reguläres Ende

note:

Modified protocol: LV5FU2 (5-FU/Leucovorin) for cycles 7-12. Oxaliplatin omitted due to persistent neuropathy. Patient tolerated modified regimen well. Completed all planned cycles.

usedCode: LV5FU2


German


Generated Narrative: Procedure mii-exa-onko-lv5fu2-phase2

MII EX Onko Systemische Therapie Intention: Kurativ

MII EX Onko Systemische Therapie Stellung zur OP: Adjuvant

basedOn: CarePlan: identifier = Tumorkonferenz_FOLFOX_Modification_001; status = active; intent = plan; category = prätherapeutische Tumorkonferenz (Festlegung der Therapiestrategie); created = 2024-03-05

partOf: Procedure Nicht komplexe Chemotherapie

status: Completed

category: Administration of medication

code: Nicht komplexe Chemotherapie

subject: Martin Beispiel Male, DoB: 1958-11-03

encounter: Encounter: status = finished; class = ambulatory (ActCode#AMB)

performed: 2024-06-17 --> 2024-09-10

reasonReference: Condition Bösartige Neubildung: Colon ascendens

outcome: Reguläres Ende

note:

Modified protocol: LV5FU2 (5-FU/Leucovorin) for cycles 7-12. Oxaliplatin omitted due to persistent neuropathy. Patient tolerated modified regimen well. Completed all planned cycles.

usedCode: LV5FU2


Source1

{
  "resourceType": "Procedure",
  "id": "mii-exa-onko-lv5fu2-phase2",
  "meta": {
    "profile": [
      "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-pr-onko-systemische-therapie"
    ]
  },
  "text": {
    "status": "extensions",
    "div": "<!-- snip (see above) -->"
  },
  "extension": [
    {
      "url": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-ex-onko-systemische-therapie-intention",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-intention",
            "code": "K",
            "display": "Kurativ"
          }
        ]
      }
    },
    {
      "url": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/StructureDefinition/mii-ex-onko-systemische-therapie-stellungzurop",
      "valueCodeableConcept": {
        "coding": [
          {
            "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-stellungzurop",
            "code": "A",
            "display": "Adjuvant"
          }
        ]
      }
    }
  ],
  "basedOn": [
    {
      "reference": "CarePlan/mii-exa-onko-tumorkonferenz-folfox-modification"
    }
  ],
  "partOf": [
    {
      "reference": "Procedure/mii-exa-onko-folfox-phase1"
    }
  ],
  "status": "completed",
  "category": {
    "coding": [
      {
        "system": "http://snomed.info/sct",
        "code": "18629005"
      }
    ]
  },
  "code": {
    "coding": [
      {
        "system": "http://fhir.de/CodeSystem/bfarm/ops",
        "version": "2024",
        "code": "8-542",
        "display": "Nicht komplexe Chemotherapie"
      },
      {
        "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-systemische-therapie-art",
        "code": "CH",
        "display": "Chemotherapie"
      }
    ]
  },
  "subject": {
    "reference": "Patient/example-modification"
  },
  "encounter": {
    "reference": "Encounter/example-chemo-phase2"
  },
  "performedPeriod": {
    "start": "2024-06-17",
    "end": "2024-09-10"
  },
  "reasonReference": [
    {
      "reference": "Condition/mii-exa-onko-ascending-colon-cancer-diagnosis"
    }
  ],
  "outcome": {
    "coding": [
      {
        "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-therapie-ende-grund",
        "code": "E",
        "display": "Reguläres Ende"
      }
    ]
  },
  "note": [
    {
      "text": "Modified protocol: LV5FU2 (5-FU/Leucovorin) for cycles 7-12. Oxaliplatin omitted due to persistent neuropathy. Patient tolerated modified regimen well. Completed all planned cycles."
    }
  ],
  "usedCode": [
    {
      "coding": [
        {
          "system": "https://www.medizininformatik-initiative.de/fhir/ext/modul-onko/CodeSystem/mii-cs-onko-systemische-therapie-protokolle",
          "code": "LV5FU2",
          "display": "LV5FU2"
        }
      ]
    }
  ]
}